AgeX Therapeutics, Inc.
AMEX:AGE
0.4302 (USD) • At close November 17, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 0.056 | 0.142 | 0.034 | 0.144 | 1.868 | 1.728 | 1.396 | 1.404 |
| Kosten van de omzet
| 0 | 0.171 | 0.013 | 0.019 | 0.158 | 0.244 | 0.364 | 0.168 |
| Brutowinst
| 0 | -0.029 | 0.021 | 0.125 | 1.71 | 1.484 | 1.032 | 1.236 |
| Brutowinstmarge
| 0 | -0.204 | 0.618 | 0.868 | 0.915 | 0.859 | 0.739 | 0.88 |
| Onderzoek- en ontwikkelingskosten
| 7.48 | 0.603 | 1.025 | 1.456 | 4.978 | 5.904 | 6.63 | 5.784 |
| Algemene en administratieve kosten
| 9.624 | 9.328 | 5.971 | 6.708 | 7.403 | 8.139 | 5.647 | 3.869 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 9.624 | 9.328 | 5.971 | 6.708 | 7.403 | 8.139 | 5.647 | 3.869 |
| Overige kosten
| 0 | 0.011 | 0.013 | 0.448 | 0.044 | 0.294 | 0.183 | 0.038 |
| Bedrijfskosten
| 17.104 | 9.931 | 6.996 | 8.164 | 12.381 | 14.043 | 12.277 | 9.653 |
| Bedrijfsresultaat
| -17.048 | -9.96 | -6.975 | -8.039 | -10.671 | -12.559 | -11.245 | -6.663 |
| Bedrijfsresultaat ratio
| -304.429 | -70.141 | -205.147 | -55.826 | -5.713 | -7.268 | -8.055 | -4.746 |
| Totaal overige inkomsten en kosten netto
| 5.907 | -4.851 | -3.547 | -0.649 | 0.272 | 0.323 | 3.514 | 1.78 |
| Inkomen voor belasting
| -11.141 | -14.811 | -10.522 | -8.582 | -11.126 | -12.236 | -7.731 | -6.637 |
| Inkomen voor belasting ratio
| -198.946 | -104.303 | -309.471 | -59.597 | -5.956 | -7.081 | -5.538 | -4.727 |
| Belastingkosten
| 0 | -0.008 | 0.152 | 1.638 | -0.15 | 0.148 | 3.514 | -1.799 |
| Nettowinst
| -11.141 | -14.803 | -10.674 | -10.22 | -10.976 | -12.384 | -7.502 | -6.58 |
| Nettowinstmarge
| -198.946 | -104.246 | -313.941 | -70.972 | -5.876 | -7.167 | -5.374 | -4.687 |
| WPA (Winst Per Aandeel)
| -1.51 | -13.72 | -9.89 | -9.49 | -10.25 | -11.69 | -7.56 | -6.46 |
| Verwaterde WPA
| -1.51 | -13.72 | -9.89 | -9.49 | -10.25 | -11.69 | -7.56 | -6.46 |
| EBITDA
| -17.048 | -9.829 | -6.975 | -7.933 | -9.152 | -11.608 | -10.71 | -9.489 |
| EBITDA ratio
| -304.429 | -69.218 | -205.147 | -55.09 | -4.899 | -6.718 | -7.672 | -6.759 |